Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC Major Shareholding Notification 2021

Apr 22, 2021

5250_rns_2021-04-22_d79f8995-4148-41de-9231-c318063d8c02.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

FORM 8.3 - WILLIS TOWERS WATSON PLC

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 21 April 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,705,364 1.32% 165,818 0.13%
(2) Derivatives (other than options):
72,359 0.06% 7,134 0.01%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,783,823 1.38% 179,052 0.14%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase 1 238.3900 USD
Purchase 5 235.5400 USD
Purchase 5 235.9500 USD
Purchase 10 235.6600 USD
Purchase 10 235.6800 USD
Purchase 10 236.0050 USD
Purchase 15 235.7133 USD
Purchase 20 235.6937 USD
Purchase 25 235.7440 USD
Purchase 41 236.0713 USD
Purchase 50 236.2726 USD
Purchase 100 236.2400 USD
Purchase 100 236.4600 USD
Purchase 200 236.0800 USD
Purchase 300 236.3650 USD
Purchase 300 236.0300 USD
Purchase 378 236.5308 USD
Purchase 400 236.4262 USD
Purchase 433 235.7446 USD
Purchase 600 236.2625 USD
Purchase 603 236.0504 USD
Purchase 677 235.9449 USD
Purchase 700 236.1900 USD
Purchase 700 236.3092 USD
Purchase 999 236.3390 USD
Purchase 1,499 236.0122 USD
Purchase 1,680 236.1584 USD
Purchase 1,791 236.3913 USD
Purchase 2,002 236.0953 USD
Purchase 2,019 236.0866 USD
Purchase 2,170 235.7369 USD
Purchase 2,314 236.3744 USD
Purchase 2,467 236.2885 USD
Purchase 2,654 236.4454 USD
Purchase 2,997 235.7400 USD
Purchase 3,404 236.2683 USD
Purchase 4,088 235.8832 USD
Purchase 10,358 235.7635 USD
Purchase 16,378 236.2454 USD
Purchase 19,527 235.9352 USD
Sale 3 235.1850 USD
Sale 7 236.4400 USD
Sale 12 235.3025 USD
Sale 27 236.1388 USD
Sale 48 235.8940 USD
Sale 50 236.2726 USD
Sale 63 236.1976 USD
Sale 63 236.2028 USD
Sale 68 236.0730 USD
Sale 75 236.2116 USD
Sale 79 236.1707 USD
Sale 81 236.2551 USD
Sale 82 236.1385 USD
Sale 84 236.3085 USD
Sale 97 236.2544 USD
Sale 100 236.0100 USD
Sale 131 236.7632 USD
Sale 133 236.0851 USD
Sale 184 235.8445 USD
Sale 186 236.1758 USD
Sale 362 235.7646 USD
Sale 426 235.8972 USD
Sale 433 235.7446 USD
Sale 840 236.1584 USD
Sale 1,440 236.0836 USD
Sale 1,654 236.1596 USD
Sale 1,897 236.1010 USD
Sale 2,171 235.7382 USD
Sale 2,358 236.3239 USD
Sale 3,092 236.2519 USD
Sale 4,137 235.7400 USD
Sale 4,688 235.9086 USD
Sale 10,251 235.7601 USD
Sale 22,848 235.9774 USD
Sale 25,000 236.2910 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 22 Apr 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210422005571/en/

BARCLAYS PLC